TABLE 2.
Baseline characteristics of 23,686 HIV-infected patients who started antiretroviral therapy between 2007 and April 2020 at 9 high-volume care sites (Conakry and Nzérékoré, Guinea. 2021).
Characteristics | N | (%) |
---|---|---|
Total | 23,686 | 100.0 |
Site area | ||
Conakry | 20,787 | 87.8 |
Interior | 2,899 | 12.2 |
Year of initiation of ART | ||
2007–2012 | 4,684 | 19.8 |
2012–2015 | 4,023 | 17.0 |
2015–2017 | 5,319 | 22.5 |
2017–2020 | 9,660 | 40.8 |
Legal status of the site | ||
Private | 2,899 | 12.2 |
Public | 20,787 | 87.8 |
Site level in the pyramid of care | ||
Level 3 | 2,899 | 12.2 |
Level 2 | 8,456 | 35.7 |
Level 1 | 12,331 | 52.1 |
Sex | ||
Women | 16,345 | 69.0 |
Man | 7,341 | 31.0 |
Age Median (IQR) | 37 (30–46) | |
Age group | ||
Adults (15 years and older) | 23,371 | 98.7 |
Children (under 15) | 315 | 1.3 |
Marital status | ||
Married | 18,072 | 76.3 |
Not married | 5,606 | 23.7 |
Missing | 8 | 0.0 |
Employment status | ||
Employee | 8,912 | 37.6 |
Unemployed | 14,764 | 62.3 |
Missing | 10 | 0.0 |
Type of HIV | ||
HIV type 1 | 23,534 | 99.4 |
Other HIV types (Type 2 or Type 1 + 2) | 132 | 0.6 |
Missing | 20 | 0.1 |
CD4 count in cells/μL, Median (IQR) (n = 23,641) | 250 (212–500) | |
Category of CD4 count in cells/μL | ||
>350 | 7,703 | 32.5 |
200–350 | 7,766 | 32.8 |
100–200 | 4,168 | 17.6 |
<100 | 4,004 | 16.9 |
Missing | 45 | 0.2 |
WHO Stage of HIV infection | ||
Early stage (I and II) | 12,381 | 52.3 |
Advanced stage (III and IV) | 11,305 | 47.7 |
ART regimens | ||
TDF + 3TC + EFV | 18,855 | 79.6 |
AZT + 3TC + NVP | 2,284 | 9.6 |
Other ART regimes of first line | 2,547 | 10.8 |
ART, antiretroviral therapy; IQR, interquartile range; n, Number of observations; WHO, World health organization; Level 1: Health center and private practice, Level 2: Regional or Prefectural hospital and private clinic that has the rank of a regional or prefectural hospital, Level 3: National hospital or private clinic that has the rank of a national hospital.